10-Q: SelectQuote Reports Increased Revenue and Income from Operations in Q2 2025

SelectQuote, Inc. reports a rise in revenue and income from operations for the quarter ended December 31, 2024, driven by growth in its Senior and Healthcare Services segments.

Summary

• SelectQuote, Inc. reported total revenue of $481.1 million for the three months ended December 31, 2024, compared to $405.4 million for the same period in 2023.
• Pharmacy revenue increased significantly to $180.0 million, up from $108.8 million in the prior year.
• Income from operations increased to $70.9 million, compared to $55.3 million in the prior year.
• Net income was $53.2 million, a substantial increase from $19.4 million in the same period last year.
• For the six months ended December 31, 2024, total revenue was $773.3 million, compared to $638.2 million in 2023.
• Net income for the six months was $8.7 million, compared to a net loss of $11.7 million in the prior year.
• The company's Senior segment saw an increase in approved policies, contributing to the revenue growth.
• The Healthcare Services segment experienced significant growth, particularly in the SelectRx pharmacy business.
• The Life segment also contributed to the overall revenue increase, driven by final expense policies.
• The company completed a $100 million securitization transaction and used the proceeds to pay down term loans.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with increased revenue and income, but also highlights some risks and challenges related to debt and future financing.

Positives

• Significant revenue growth in the Healthcare Services segment, particularly in the SelectRx pharmacy business.
• Increased income from operations and net income compared to the previous year.
• Growth in the Senior segment, driven by an increase in approved policies.
• Successful completion of a securitization transaction to pay down debt.
• The company is in compliance with all financial covenants pursuant to its debt obligations.
• The company entered into Senior Preferred Stock Purchase Agreements for an aggregate investment of $350 million, expected to close on February 28, 2025.

Negatives

• Marketing and advertising expenses decreased, which could impact future lead generation.
• The LTV per MA approved policy decreased slightly due to carrier mix.
• The Auto & Home segment experienced a decrease in commissions revenue due to a change in strategic direction.
• The company is currently in a three-year cumulative loss position, which impacts the valuation allowance analysis for deferred tax assets.

Risks

• The company's reliance on a few major insurance carrier customers poses a concentration risk.
• The company may not generate sufficient cash flows from operations to enable it to make the remaining milestone payments contemplated in the Eleventh Amendment.
• If the company is unable to secure additional financing from outside sources or otherwise amend the Senior Secured Credit Facility, it will need to obtain additional capital through other means, including future securitization transactions, selling one or more material assets, or substantially reducing the scope of certain of its operations.
• If the company is unable to satisfy its repayment obligations under the Senior Secured Credit Facility or maintain compliance with the covenants therein, it may be in default, which would significantly affect its liquidity.

Future Outlook

The company expects that its existing cash, cash equivalents, funds available under the revolving credit facility, and cash provided from operations will be sufficient to finance normal working capital needs, investments in properties, facilities and equipment, and debt services. The company will use the proceeds from the Senior Preferred Stock Purchase Agreements to pay down debt and fund operations.

Industry Context

SelectQuote operates in the technology-enabled, direct-to-consumer insurance distribution market, competing with other online insurance marketplaces and direct insurance providers. The company's focus on technology and data analytics aims to provide a competitive advantage in lead generation and customer engagement. The growth in the Healthcare Services segment reflects a broader trend of healthcare companies expanding into integrated service offerings.

Comparison to Industry Standards

• SelectQuote's revenue growth in the Senior segment aligns with the overall expansion of the Medicare Advantage market, where companies like Humana and UnitedHealth Group are also experiencing growth.
• The company's focus on LTV is a common metric in the insurance industry, used by companies like eHealth, Inc. to assess the profitability of customer acquisition.
• The growth of SelectRx is comparable to other pharmacy benefit managers (PBMs) and mail-order pharmacies, such as CVS Caremark and Express Scripts, that are focused on improving medication adherence and patient outcomes.
• The company's securitization transaction is a financing strategy used by other insurance brokers and financial services companies to monetize future commission streams.

Legal Proceedings

• The company is involved in a Securities Class Action and a Stockholder Derivative Suit, but currently believes that these matters will not have a material adverse effect on its operations, financial condition or liquidity.

Related Party Transactions

• SelectRx leases the Monaca facility from an Executive Vice President of SelectRx.

Stakeholder Impact

• The company's performance impacts shareholders through stock value and potential dividends.
• Employees are affected by the company's financial stability and growth prospects.
• Customers benefit from the company's services in providing insurance and healthcare solutions.
• Insurance carrier partners rely on the company for policy distribution and revenue generation.
• Creditors are impacted by the company's ability to meet its debt obligations.

Next Steps

• The company will use the proceeds from the Senior Preferred Stock Purchase Agreements to pay down debt and fund operations.
• The company will continue to evaluate the realizability of its deferred tax assets.
• The company will continue to monitor and manage its debt covenants.
• The issuance of the Preferred Stock and Preferred Warrants pursuant to the Senior Preferred Stock Purchase Agreements will occur on February 28, 2025.

Key Dates

Keywords

SelectQuote, revenue, pharmacy, Medicare Advantage, insurance, commissions, SelectRx, EBITDA, securitization, debt